Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelHartmut Döhner, Clara D. Bloomfield, Bob Löwenberg et al.|Blood|2016Cited by 5.9k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetHartmut Döhner, Clara D. Bloomfield, Elihu H. Estey et al.|Blood|2009Cited by 3.4k
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialDavid Grimwade, Anthony P. Goldstone|Blood|1998Cited by 2.6k
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsDavid Grimwade, Alan K. Burnett|Blood|2010Cited by 1.9k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit Jan Schuurhuis, Gert J. Ossenkoppele, Michael Heuser et al.|Blood|2018Cited by 1k